Liaw, Y.F. & Chu, C.M. Hepatitis B virus infection. Lancet 373, 582–592 (2009).
Sener, S.F. Disease without borders. CA Cancer J. Clin. 55, 7–9 (2005).
Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011).
Custer, B. et al. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38, S158–S168 (2004).
Beasley, R.P., Hwang, L.Y., Lin, C.C. & Chien, C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2, 1129–1133 (1981).
He, Y.L., Zhao, Y.R., Zhang, S.L. & Lin, S.M. Host susceptibility to persistent hepatitis B virus infection. World J. Gastroenterol. 12, 4788–4793 (2006).
Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591–595 (2009).
Mbarek, H. et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 20, 3884–3892 (2011).
Nishida, N. et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 7, e39175 (2012).
Green, M.S. et al. Use of predictive value to adjust relative risk estimates biased by misclassification of outcome status. Am. J. Epidemiol. 117, 98–105 (1983).
Han, Y. et al. Association of human leukocyte antigen–DRB1 alleles with chronic hepatitis B virus infection in the Han Chinese of Northeast China. Mol. Med. Rep. 5, 1347–1351 (2012).
Li, X. et al. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Virus Res. 163, 328–333 (2012).
Kummee, P. et al. Association of HLA-DRB1*13 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J. Viral Hepat. 14, 841–848 (2007).
Zeller, T. et al. Genetics and beyond—the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5, e10693 (2010).
Pique-Regi, R. et al. Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res. 21, 447–455 (2011).
An, P., Winkler, C., Guan, L., O'Brien, S.J. & Zeng, Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J. Infect. Dis. 203, 943–947 (2011).
Guo, X. et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53, 422–428 (2011).
Hu, L. et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55, 1426–1431 (2012).
Li, J. et al. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS ONE 6, e24221 (2011).
Thomas, R. et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J. Virol. 86, 6979–6985 (2012).
Vermehren, J. et al. A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS ONE 7, e32605 (2012).
Wang, L. et al. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS ONE 6, e17608 (2011).
O'Brien, T.R. et al. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun. 12, 428–433 (2011).
Thio, C.L. et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J. Infect. Dis. 179, 1004–1006 (1999).
Díaz, G. et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPβ residues 9, 11, 35, 55, 56, 69 and 84–87 in T cell allorecognition and peptide binding. Int. Immunol. 15, 565–576 (2003).
Chang, J.J. et al. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79, 3038–3051 (2005).
Dubois, P.C. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295–302 (2010).
Fransen, K. et al. Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum. Mol. Genet. 19, 3482–3488 (2010).
Hüffmeier, U. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 42, 996–999 (2010).
Wang, S. et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 13, 380–387 (2012).
Zhernakova, A. et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 7, e1002004 (2011).
Ballardini, G. et al. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin. Exp. Immunol. 70, 35–46 (1987).
Zhang, Y. et al. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 121, 105–112 (2007).
Chen, W. et al. HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus–specific cytotoxic T lymphocytes. Hepatol. Res. 39, 355–365 (2009).
Chen, J.H. et al. Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice. Hepat. Mon. 11, 620–628 (2011).
Montgomery, S.B. et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773–777 (2010).
Moynihan, T.P. et al. Fine-mapping, genomic organization, and transcript analysis of the human ubiquitin-conjugating enzyme gene UBE2L3. Genomics 51, 124–127 (1998).
Staib, F., Hussain, S.P., Hofseth, L.J., Wang, X.W. & Harris, C.C. TP53 and liver carcinogenesis. Hum. Mutat. 21, 201–216 (2003).
Norton, P.A. et al. Activation of fibronectin gene expression by hepatitis B virus x antigen. J. Viral Hepat. 11, 332–341 (2004).
Bertoletti, A. et al. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61, 1754–1764 (2012).
Li, S. et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 8, e1002791 (2012).
Du, G. et al. Sero-epidemiological surveys of hepatitis B in different populations in Zhangjiagang city. Mod. Prev. Med. 23, 4560–4563 (2009).
Fang, Y. et al. Investigation of the serum markers of hepatitis B virus among 2378 physical examination takers in Shanghai. Occup. Health (Lond.) 4, 350–351 (2008).
Liang, X. et al. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 27, 6550–6557 (2009).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Delaneau, O., Marchini, J. & Zagury, J.F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181 (2012).